ArticleBioscience reports2019

MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway.

Hong Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.